phenoxodiol

DRUG3 trials

Sponsors

MEI Pharma, Inc.

Conditions

Fallopian Tube CancerOvarian CancerPeritoneal NeoplasmsPrimary Peritoneal Cavity CancerProstate Cancer

Phase 1

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

CompletedNCT00091377

MEI Pharma, Inc.Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2004-08-31End: 2008-03-31Updated: 2016-07-14

Phase 2

A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer

CompletedNCT00557037

MEI Pharma, Inc.Prostate Cancer

Start: 2007-11-30End: 2009-11-30Target: 60Updated: 2010-04-08

Phase 3

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer

CompletedNCT00382811

MEI Pharma, Inc.Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms

Start: 2006-10-31End: 2011-04-30Updated: 2016-07-18